Neuried, Germany

Thomas Pohl

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of Thomas Pohl

Introduction

Thomas Pohl is a notable inventor based in Neuried, Germany. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of soluble Fc receptors. With a total of seven patents to his name, Pohl's work has the potential to impact the treatment of various autoimmune diseases and infections.

Latest Patents

Among his latest patents, Pohl has developed highly concentrated formulations of soluble Fc receptors. These formulations specifically focus on high concentrations of the soluble FcγRIIB receptor. The invention relates to the use of these formulations as pharmaceutical compounds for treating autoimmune diseases, infections, and other conditions where the immune system plays a crucial role.

Career Highlights

Throughout his career, Thomas Pohl has worked with several companies, including Suppremol GmbH and Lifecodexx AG. His expertise in the field has allowed him to contribute to innovative solutions in pharmaceutical science.

Collaborations

Pohl has collaborated with notable individuals in his field, including Peter Sondermann and Dominik Ter Meer. These collaborations have further enhanced his research and development efforts.

Conclusion

Thomas Pohl's contributions to the field of pharmaceutical formulations demonstrate his commitment to innovation and improving healthcare solutions. His patents and collaborations reflect a dedication to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…